Valacyclovir 500mgTablet
Antiviral

Valacyclovir 500mg

Valacyclovir Hydrochloride

L-valyl ester prodrug of acyclovir with 3-5 times higher oral bioavailability, enabling simplified twice or three-times-daily dosing versus acyclovir's five-daily regimen. Preferred for herpes zoster management and uniquely effective as single-day therapy for herpes labialis, significantly improving patient adherence over standard acyclovir courses.

Strengths

500mg / 1000mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Valacyclovir Hydrochloride 500mg / 1000mg
Dosage Form
Tablet
Available Strengths
500mg / 1000mg
Packing
10 tablets/strip
Route of Administration
Oral, with or without food
Dosage
Cold sores: 2g twice daily for 1 day; Genital herpes: 500mg-1g twice daily for 3-10 days; Zoster: 1g three times daily for 7 days; Suppression: 500mg-1g once daily
Indications
Herpes labialis, genital herpes (recurrent and suppression), herpes zoster, CMV prophylaxis in transplant recipients
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C, protected from moisture
Shelf Life
36 months
Side Effects
Headache, nausea, diarrhea, vomiting, abdominal pain; at high doses in immunocompromised: TTP/HUS (rare)
Precautions
Dose adjustment in renal impairment; TTP/HUS risk with high doses in immunocompromised patients; maintain adequate hydration; not curative for herpes

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Acyclovir 400mgTablet

Acyclovir 400mg

Acyclovir

First clinically successful selective antiviral and WHO Essential Medicine — a guanosine analog phosphorylated exclusively by herpes-virus thymidine kinase to specifically inhibit viral DNA polymerase. Foundational therapy for HSV and VZV infections across all age groups with a four-decade safety record in oral and intravenous formulations.

200mg / 400mg / 800mg
Oseltamivir 75mgCapsule

Oseltamivir 75mg

Oseltamivir Phosphate

Competitive neuraminidase inhibitor preventing influenza virus budding and spread from infected respiratory cells, reducing illness duration by 1-2 days when initiated within 48 hours of symptom onset. WHO pandemic stockpile antiviral recommended as first-line treatment for severe influenza in high-risk populations including the elderly, immunocompromised, and young children.

30mg / 45mg / 75mg
Favipiravir 400mgTablet

Favipiravir 400mg

Favipiravir

Broad-spectrum RNA-dependent RNA polymerase inhibitor that is incorporated into viral RNA as a fraudulent purine nucleotide, causing lethal mutagenesis across multiple RNA viruses. Approved in Japan for influenza and granted emergency use authorization in India and Russia for COVID-19, with Glenmark and Cipla among India's first manufacturers to supply this strategic antiviral.

200mg / 400mg

Need bulk pricing for Valacyclovir 500mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote